drugset / Trial / NCT04521023
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
RandomizedParallel-groupDouble-blindTreatment
Summary
Phase 4 clinical trial to Evaluate the blood pressure lowering effect of a Candesartan/Hydrochlorothiazide(Candemore Plus Tab) versus Candesartan/Amlodipine(Cantabell Tab) in Hypertensive Patients
Timeline
- Start
- 2017-09-20
- Primary completion
- 2020-01-28
- Completion
- 2020-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | — | — |
| Comparator | Hydrochlorothiazide | Unknown | — | — |
| Comparator | Candesartan | Unknown | — | — |